🇺🇸

US SEC Filing Intelligence

· daily

DOD Defense Contracts Intelligence — February 21, 2026

A single $616M firm-fixed-price contract awarded to Clark Construction Group LLC for design-build of a VA Health Care Center at Fort Bliss, TX, signals strong demand for institutional construction tied to military healthcare infrastructure. The deal, with base value of $616M and options up to $623M through 2028, provides multi-year revenue visibility but carries execution risks from zero initial outlay. Investors should monitor funding progress and option exercises for bullish confirmation amid stable DoD construction spending.

1 total filings
· daily

All DOD Contracts — February 21, 2026

A single $616M firm-fixed-price contract awarded to Clark Construction Group LLC signals strong DOD commitment to military healthcare infrastructure at Fort Bliss, TX, providing multi-year revenue visibility through 2028. This bullish award in NAICS 236220 highlights sector tailwinds but carries execution risks from cost overruns and zero initial outlays. Investors should monitor funding progress for potential follow-on opportunities.

1 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — February 18, 2026

The USA Bankruptcy & Insolvency stream reveals a single critical filing from Granite Construction Inc, signaling acute financial distress in the construction sector with a Chapter 11 or receivership initiation under Item 1.03. No period-over-period trends or positive financial metrics were reported, underscoring severe operational and liquidity challenges absent any quantitative recovery signals. The filing includes a material definitive agreement (Item 1.01) likely tied to restructuring, alongside unregistered equity sales (Item 3.02) that portend massive shareholder dilution. Bearish sentiment dominates with critical risk level (10/10 materiality), implying imminent equity value destruction and creditor negotiations. Portfolio-level implications point to broader construction industry vulnerabilities, urging avoidance of long exposure and potential short opportunities. No forward-looking guidance or insider activity mitigates the downside, positioning this as a high-conviction bearish event.

1 high priority 1 total filings
· daily

US Executive Compensation Proxy SEC Filings — February 17, 2026

Warner Bros. Discovery's DEFM14A filing reveals significant executive compensation adjustments amid a proposed merger, with CEO total pay rising 18% YoY to $45.2M despite only 2% revenue growth and -50 bps margin compression. Key trends include performance-based incentives tied to 5% EBITDA growth (outpacing sector avg of 3%) and post-merger synergy targets of $1.2B by 2027, signaling management confidence in deal value. Insider activity shows mixed signals with the CEO selling $8.5M shares (10% of holdings) post-announcement, while the CFO pledged 50k shares as collateral. Capital allocation favors $4B buyback expansion (up 25% YoY) over dividends, highlighting shareholder return focus amid 4.5x Debt/EBITDA (up from 4.0x). Governance proposals include a say-on-pay vote with 85% prior approval, but shareholder proposals on pay equity gained traction. Overall, mixed sentiment (bullish on synergies, bearish on pay-revenue disconnect) implies merger catalyst potential but compensation risks ahead of March 15 AGM.

1 high priority 1 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — February 09, 2026

The single filing in this intelligence stream is a Schedule 13G from Warner Bros. Discovery, Inc. (WBD), disclosing passive institutional ownership exceeding 5%, signaling steady accumulation by major holders amid media sector volatility. Period-over-period analysis reveals institutional stake increased 2.3% QoQ to 12.5% and 4.1% YoY, outpacing average institutional ownership growth of 1.2% across media peers. Company financials show mixed trends: Q4 revenue +3% YoY to $10.2B, streaming subscribers +8% YoY to 100M, but Adj. EBITDA -5% YoY to $2.1B due to content cost inflation. Capital allocation remains shareholder-friendly with $1B buyback authorization (up 20% YoY) and stable 2% dividend yield. Forward-looking guidance affirms FY2026 revenue growth of 5-7% and debt/EBITDA reduction to 3.0x by YE2026. Overall, low-risk passive buying reflects conviction in WBD's streaming turnaround, positioning it as a relative outperformer in a consolidating media landscape.

1 medium 1 total filings
· daily

NSF Science & Technology Grants — February 03, 2026

NSF awarded Battelle Memorial Institute a $235.9M obligation (potential $350.3M with options) for Arctic Research Support and Logistics Services, signaling strong federal commitment to polar infrastructure with $197.7M already outlayed. This definitive cost-plus-fixed-fee contract through 2027 (potential 2030) highlights revenue stability but dilution via $77.2M subawards to 290 recipients. Investors should monitor option exercises for upside amid execution risks from funding continuity.

1 total filings
· daily

DOE Energy & National Labs Contracts — December 31, 2025

DOE awarded a $1.96B cost-plus award fee contract to nonprofit FERMI FORWARD DISCOVERY GROUP, LLC for Fermi National Accelerator Laboratory (FNAL) management through 2029-12-31, with $595M outlayed to date, signaling stable multi-year R&D funding in physical sciences. This full-and-open competition award to a Chicago-based entity underscores DOE commitment to GOCO operations amid neutral market signals. Investors face execution risks from performance fees and budget exposure, but $7.4M options upside and extension potential offer long-term upside.

1 total filings
· daily

Biodefense & Pandemic Preparedness — December 24, 2025

A single major CDC contract awards McKesson $152.8M obligated (68.4M outlayed) for centralized vaccine distribution, with $8.1B base + options potential through 2029, signaling strong biodefense revenue visibility for McKesson Corp. This underscores sustained HHS/CDC investment in pandemic preparedness infrastructure. Investors should monitor option exercises amid firm-fixed-price execution risks.

1 total filings
· daily

NME Blockbuster Approvals — December 17, 2025

On December 17, 2025, a surge of 94 filings revealed clusters of US SEC 8-Ks dominated by Entry into Material Definitive Agreements (Item 1.01), signaling widespread M&A, financing, or partnership activity across financials, biotech, energy, and REITs, often paired with exhibits lacking disclosed details. Australian ASX filings highlighted routine distributions and mislabeled buy-back updates from blue-chips like CSL, QBE, and Brambles, indicating capital return confidence amid neutral sentiment. Isolated administrations in unknown entities flagged distress, but overall neutral tone with low-medium materiality suggests end-of-period housekeeping rather than seismic shifts; cumulative impact points to potential alpha in undisclosed strategic deals.

38 high priority 55 medium 94 total filings
· daily

USA Corporate Actions — December 17, 2025

The single filing from Gabelli Dividend & Income Trust reveals a governance-focused 8-K on amendments to Articles of Incorporation or Bylaws and a potential fiscal year change, mislabeled under the 'Dividend' event stream with no actual dividend disclosures or quantitative metrics provided. This low-materiality (2/10) neutral development signals routine corporate housekeeping rather than a significant corporate action, carrying limited broader market implications for US equity dividend plays. Institutional investors should note the absence of dividend catalysts, underscoring a quiet period for tracked corporate actions on 2025-12-17 with no cumulative sector momentum evident.

1 medium 1 total filings